Press release: August 2009
To further strengthen its highly successful Healthcare team -already a world leader in the testing and certification of medical devices - BSI has appointed Dr. Gert Bos as Head of Regulatory and Clinical Affairs per 1 September 2009.
In his new role, Gert will focus on strengthening BSI’s role in the regulatory work at a European Union level in Brussels, supporting complex drug-device and animal tissue combination projects and increase BSI’s competence in the evaluation of clinical data.
Gert Bos has a PhD in blood material interactions and has dealt extensively with both drugs and devices in a a scientific and R&D environment before joining a Notified Body. He has been an active participant to the regulatory committees in Brussels and currently holds the position of chairman of NB-MED, where Notified Bodies, industry and commission meet to discuss interpretations of the medical device directives. Furthermore he has extensive experience in classification discussions and as a Notified Body auditor and product reviewer with a variety of vascular devices. With Gert, BSI further expands its leadership role in the European regulatory environment.
“We’re delighted that Gert is joining our team,” said David Ford, Managing Director, BSI Healthcare and Testing. “His experience and knowhow in market sectors that are strategically important for our healthcare business will, without doubt, bring big benefits not just for us, but also for our customers.”
“After having appointed Jan van Lochem as Vice President Healthcare for EMEA and AsiaPac earlier this year, Gert’s appointment shows BSI's full commitment to quality, customer focus and investment in the healthcare market.”.